INTSIntensity Therapeutics - Common StockINTS info
$4.17info2.46%24h
Global rank24690
Market cap$57.17M
Change 7d-
YTD Performance-50.88%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Intensity Therapeutics - Common Stock (INTS) Stock Overview

    Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. Its lead product candidate includes INT230-6, a clinical trial for the treatment of refractory solid tumors and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. The company was incorporated in 2012 and is headquartered in Westport, Connecticut.

    INTS Stock Information

    Symbol
    INTS
    Address
    61 Wilton RoadWestport, CT 06880United States
    Founded
    -
    Trading hours
    -
    Website
    https://intensitytherapeutics.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    203 221 7381

    Intensity Therapeutics - Common Stock (INTS) Price Chart

    -
    Value:-

    Intensity Therapeutics - Common Stock Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $4.17
    N/A
    Market Cap
    $57.17M
    N/A
    Shares Outstanding
    13.71M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org